GEFTINAT 250MG TABLET

Tablet
Rs.5900for 1 strip(s) (30 tablets each)
1
Unfortunately, we don't have any more items in stock
Available in other variants
Report Error

Composition FOR GEFTINAT 250mg tablet

Gefitinib(250mg)

food interaction for GEFTINAT tablet

alcohol interaction for GEFTINAT tablet

pregnancy interaction for GEFTINAT tablet

lactation interaction for GEFTINAT tablet

food
alcohol
pregnancy
lactation
It can be taken with or without food, but it is better to take Geftinat 250mg tablet at a fixed time.
Interaction with alcohol is unknown. Please consult your doctor.
Geftinat 250mg tablet is unsafe to use during pregnancy.
There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
WEIGH RISKS VS. BENEFITS
Geftinat 250mg tablet is probably unsafe to use during breastfeeding. Please consult your doctor.
UNSAFE

SALT INFORMATION FOR GEFTINAT 250mg tablet

Gefitinib(250mg)

Geftinat tablet uses

Geftinat 250mg tablet is used in the treatment of small cell lung cancer.

How geftinat tablet works

In patients with cancer, a change in DNA (genetic material) triggers a signal which produces abnormal cancer cells. Geftinat 250mg tablet blocks this signal, and thus stops the production of these cancer cells.

Common side effects of geftinat tablet

Nausea, Rash, Vomiting, Weakness, Loss of appetite, Dry skin, Diarrhoea, Stomatitis (Inflammation of the mouth).

COMMON DOSAGE FOR GEFTINAT 250MG TABLET

Patients taking GEFTINAT 250MG TABLET

  • 89%
    Once A Day
  • 11%
    Twice A Day

SUBSTITUTES FOR GEFTINAT tablet

23 Substitutes
23 Substitutes
Sorted By
RelevancePrice
  • XEFTA 250MG TABLET
    (10 tablets in strip)
    Dr Reddy's Laboratories Ltd
    Rs. 387.19/tablet
    Tablet
    Rs. 3871.92
    pay 97% more per tablet
  • ZUFINIB 250MG TABLET
    (10 tablets in strip)
    Zuventus Healthcare Ltd
    Rs. 300.26/tablet
    Tablet
    Rs. 3002.62
    pay 53% more per tablet
  • GEFTIB 250MG TABLET
    (30 tablets in strip)
    Glenmark Pharmaceuticals Ltd
    Rs. 128.25/tablet
    Tablet
    Rs. 3847.56
    save 35% more per tablet
  • CHEMORESSA 250MG TABLET
    (10 tablets in strip)
    Biochem Pharmaceutical Industries
    Rs. 328.57/tablet
    Tablet
    Rs. 3285.71
    pay 67% more per tablet
  • GEFITRUST 250MG TABLET
    (10 tablets in strip)
    Panacea Biotec Ltd
    Rs. 317.93/tablet
    Tablet
    Rs. 3179.30
    pay 62% more per tablet

Top Medical Oncologists

Expert advice FOR GEFTINAT tablet

  • Do not take antacids (to reduce the acid level of your stomach) 2 hours before or 1 hour after taking gefitinib.
  • Take the tablet at about the same time each day.
  • Do not give gefitinib to children.
  • Do not take gefitinib, if you are allergic to gefitinib or similar medicines or to any of the other ingredients.
  • Avoid using gefitinib, if you are pregnant or are breast-feeding.
  • Avoid becoming pregnant during treatment with gefitinib because it could harm your baby.
  • If you are taking a medicine containing warfarin as an active substance, your doctor may need to do blood tests more often.
  • You may feel weak while taking this medicine, be careful while driving or using tools or machines.

Frequently asked questions FOR GEFTINAT 250mg tablet

Gefitinib

Q. Is gefitinib a chemotherapy/monoclonal antibody/what is gefitinib used for/ what is gefitinib tablets/ what is gefitinib 250/Does gefitinib cure lung cancer?
Gefitinib (250 mg) is used to treat adults with non-small cell lung cancer. It is used as an adjunct to other chemotherapies. It is not a monoclonal antibody
Q. Is gefitinib effective/does gefitinib work?
Gefitinib is effective and works for most patients if taken at recommended dosage and duration
Q. How is gefitinib administered?
Gefitinib is taken orally.

WHAT OUR USERS ARE SAYING ABOUT GEFTINAT 250MG TABLET

How effective is this medicine?

Effective
63%
Can't say
38%

Do you find this medicine expensive?

Yes
86%
No
14%

Articles


Content on this page was last updated on 08 March, 2017, by Dr. Varun Gupta (MD Pharmacology)